Literature DB >> 21640702

Interaction of aryl hydrocarbon receptor and NF-κB subunit RelB in breast cancer is associated with interleukin-8 overexpression.

Christoph Franz Adam Vogel1, Wen Li, Dalei Wu, Jamie K Miller, Colleen Sweeney, Gwendal Lazennec, Yasuko Fujisawa, Fumio Matsumura.   

Abstract

The aryl hydrocarbon receptor (AhR) has been best known for its role in mediating the toxicity of dioxin. Here we show that AhR overexpression is found among estrogen receptor (ER)α-negative human breast tumors and that its overexpression is positively correlated to that of the NF-κB subunit RelB and Interleukin (IL)-8. Increased DNA binding activity of the AhR and RelB is coupled to IL-8 overexpression in primary breast cancer tissue, which was also supported by in situ hybridization. Activation of AhR in vitro by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induced IL-8 expression in MDA-MB 436 and MCF-7 cells in an AhR and RelB dependent manner. Consistently, downregulation of RelB or AhR by small interfering RNAs (siRNA) decreased the level of IL-8 but increased expression of ERα in vitro in MCF-7 cells. Our results strongly suggest that RelB and AhR have a critical role in the regulation of IL-8 and reveal a supportive role of RelB and AhR in the anti-apoptotic response in human breast cancer cells. AhR and RelB may present a novel therapeutic target for inflammatory driven breast carcinogenesis and tumor progression. Overexpression of pro-survival factors AhR and RelB may explain the process of the development of environmentally-induced type of breast cancers.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21640702      PMCID: PMC3135412          DOI: 10.1016/j.abb.2011.05.011

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  32 in total

1.  Expression of the aryl hydrocarbon receptor/transcription factor (AhR) and AhR-regulated CYP1 gene transcripts in a rat model of mammary tumorigenesis.

Authors:  A F Trombino; R I Near; R A Matulka; S Yang; L J Hafer; P A Toselli; D W Kim; A E Rogers; G E Sonenshein; D H Sherr
Journal:  Breast Cancer Res Treat       Date:  2000-09       Impact factor: 4.872

2.  Direct action of estrogen on sequence of progression of human preneoplastic breast disease.

Authors:  M P Shekhar; P Nangia-Makker; S R Wolman; L Tait; G H Heppner; D W Visscher
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

3.  Redefining cancer research.

Authors:  Bruce Alberts
Journal:  Science       Date:  2009-09-11       Impact factor: 47.728

Review 4.  The aryl hydrocarbon receptor: studies using the AHR-null mice.

Authors:  F J Gonzalez; P Fernandez-Salguero
Journal:  Drug Metab Dispos       Date:  1998-12       Impact factor: 3.922

Review 5.  Hormonal carcinogenesis.

Authors:  B E Henderson; H S Feigelson
Journal:  Carcinogenesis       Date:  2000-03       Impact factor: 4.944

Review 6.  Xenograft models of premalignant breast disease.

Authors:  F R Miller
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-10       Impact factor: 2.673

7.  RelB enhances prostate cancer growth: implications for the role of the nuclear factor-kappaB alternative pathway in tumorigenicity.

Authors:  Yong Xu; Sajni Josson; Fang Fang; Terry D Oberley; Daret K St Clair; X Steven Wan; Yulan Sun; Vasudevan Bakthavatchalu; Anantharaman Muthuswamy; William H St Clair
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

8.  Mechanisms underlying differential expression of interleukin-8 in breast cancer cells.

Authors:  Ariane Freund; Valérie Jolivel; Sébastien Durand; Nathalie Kersual; Dany Chalbos; Carine Chavey; Françoise Vignon; Gwendal Lazennec
Journal:  Oncogene       Date:  2004-08-12       Impact factor: 9.867

9.  MCF10AT: a model for the evolution of cancer from proliferative breast disease.

Authors:  P J Dawson; S R Wolman; L Tait; G H Heppner; F R Miller
Journal:  Am J Pathol       Date:  1996-01       Impact factor: 4.307

10.  Characterization of MCF mammary epithelial cells overexpressing the Arylhydrocarbon receptor (AhR).

Authors:  Patrick S Wong; Wen Li; Christoph F Vogel; Fumio Matsumura
Journal:  BMC Cancer       Date:  2009-07-15       Impact factor: 4.430

View more
  24 in total

1.  Genome-Wide Transcriptional Analysis Reveals Novel AhR Targets That Regulate Dendritic Cell Function during Influenza A Virus Infection.

Authors:  Anthony M Franchini; Jason R Myers; Guang-Bi Jin; David M Shepherd; B Paige Lawrence
Journal:  Immunohorizons       Date:  2019-06-17

Review 2.  Aryl hydrocarbon receptor ligands in cancer: friend and foe.

Authors:  Iain A Murray; Andrew D Patterson; Gary H Perdew
Journal:  Nat Rev Cancer       Date:  2014-12       Impact factor: 60.716

3.  A delayed proinflammatory response of human preadipocytes to PCB126 is dependent on the aryl hydrocarbon receptor.

Authors:  Francoise A Gourronc; Larry W Robertson; Aloysius J Klingelhutz
Journal:  Environ Sci Pollut Res Int       Date:  2017-07-11       Impact factor: 4.223

4.  The aryl hydrocarbon receptor (AhR) mediates resistance to apoptosis induced in breast cancer cells.

Authors:  Kanae Bekki; Helena Vogel; Wen Li; Tomohiro Ito; Colleen Sweeney; Thomas Haarmann-Stemmann; Fumio Matsumura; Christoph F A Vogel
Journal:  Pestic Biochem Physiol       Date:  2014-12-23       Impact factor: 3.963

5.  Recurrent exon-deleting activating mutations in AHR act as drivers of urinary tract cancer.

Authors:  Ewart Kuijk; Edwin Cuppen; Judith M Vlaar; Anouska Borgman; Eric Kalkhoven; Denise Westland; Nicolle Besselink; Charles Shale; Bishoy M Faltas; Peter Priestley
Journal:  Sci Rep       Date:  2022-06-16       Impact factor: 4.996

6.  Smoke carcinogens cause bone loss through the aryl hydrocarbon receptor and induction of Cyp1 enzymes.

Authors:  Jameel Iqbal; Li Sun; Jay Cao; Tony Yuen; Ping Lu; Itai Bab; N Adrian Leu; Satish Srinivasan; Sagie Wagage; Christopher A Hunter; Daniel W Nebert; Mone Zaidi; Narayan G Avadhani
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-17       Impact factor: 11.205

Review 7.  Aryl hydrocarbon receptor and experimental autoimmune arthritis.

Authors:  Nam Trung Nguyen; Taisuke Nakahama; Tadamitsu Kishimoto
Journal:  Semin Immunopathol       Date:  2013-08-27       Impact factor: 9.623

8.  The aryl hydrocarbon receptor repressor - More than a simple feedback inhibitor of AhR signaling: Clues for its role in inflammation and cancer.

Authors:  Christoph F A Vogel; Thomas Haarmann-Stemmann
Journal:  Curr Opin Toxicol       Date:  2017-03-01

9.  Endogenous aryl hydrocarbon receptor promotes basal and inducible expression of tumor necrosis factor target genes in MCF-7 cancer cells.

Authors:  Travis B Salisbury; Justin K Tomblin; Donald A Primerano; Goran Boskovic; Jun Fan; Inderjit Mehmi; Jackie Fletcher; Nalini Santanam; Estil Hurn; Gary Z Morris; James Denvir
Journal:  Biochem Pharmacol       Date:  2014-06-24       Impact factor: 5.858

10.  Alternaria alternata Mycotoxins Activate the Aryl Hydrocarbon Receptor and Nrf2-ARE Pathway to Alter the Structure and Immune Response of Colon Epithelial Cells.

Authors:  Julia Groestlinger; Veronika Spindler; Gudrun Pahlke; Michael Rychlik; Giorgia Del Favero; Doris Marko
Journal:  Chem Res Toxicol       Date:  2022-04-11       Impact factor: 3.973

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.